IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.15
-1.19% today
Updated 2026-04-29
Market cap
$658.76M
P/E ratio
26.93
P/S ratio
2.22x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$1 – $6
Volume
2.8M
Ironwood Pharmaceuticals Inc (IRWD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-25.9%
Last 4 quarters
Revenue YoY growth
-47.3%
Most recent quarter
EPS YoY growth
-150.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+25.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+50.5%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $-0.01 | -159.5% | $4.44 | $4.50 | +1.4% |
| 2025-11-10 | $0.24 | +118.2% | $1.92 | $2.89 | +50.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.02 | $-0.01 | -159.5% | $47.71M | -47.3% |
| 2025-09-30 | $0.11 | $0.24 | +118.2% | $122.06M | +33.3% |
| 2025-06-30 | $0.03 | $0.14 | +366.7% | $85.24M | -9.7% |
| 2025-03-31 | $0.20 | $-0.14 | -170.0% | $41.14M | -45.1% |
| 2024-12-31 | $0.08 | $0.02 | -74.2% | $90.55M | -23.0% |
| 2024-09-30 | $0.08 | $0.02 | -75.0% | $91.59M | -19.5% |
| 2024-06-30 | $0.15 | $-0.01 | -103.6% | $94.40M | -12.1% |
| 2024-03-31 | $0.19 | $-0.02 | -110.5% | $74.88M | -28.0% |
| 2023-12-31 | $0.21 | $-0.01 | -104.8% | $117.55M | — |
| 2023-09-30 | $0.16 | $0.09 | -43.8% | $113.74M | — |
| 2023-06-30 | $0.25 | $0.31 | +24.0% | $107.38M | — |
| 2023-03-31 | $0.24 | $0.25 | +4.2% | $104.06M | — |
Frequently asked questions
Has Ironwood Pharmaceuticals Inc beaten earnings estimates?
Ironwood Pharmaceuticals Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -25.9% over the last 2 quarters.
How does IRWD stock react to earnings?
IRWD stock has moved an average of +25.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Ironwood Pharmaceuticals Inc's revenue growth rate?
Ironwood Pharmaceuticals Inc reported year-over-year revenue growth of -47.3% in its most recent quarter, with EPS growing -150.0% year-over-year.